Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial Pharmaceutical Investing
Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19 Pharmaceutical Investing
Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure Cannabis Investing News
Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test Biotech Investing
Primo Nutraceuticals Signs LOI to enter in to Funding and Share Purchase Agreement for 25 Percent with Beauty Kitchen Cannabis Investing News
BriaCell to Present Clinical Data at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 Biotech Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
